Furthermore, missense mutations in the Smad2 and Smad4 genes occurring in colon and pancreatic cancer cells, respectively, have been reported to inhibit association of Smad2 with Smad4 [54]. This evidence concerns the gene SMAD2 and pancreatic neoplasm.